Diabetes Clinical Trials in Philadelphia

Showing 21-40 of 625 trials

A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus

NCT06362265

The main purpose of this study is to evaluate how much of LY3209590 gets into the blood stream after a single dose and how long it takes the body to remove it in pediatric participants with Type 2 Diabetes Mellitus (T2DM). The study will last for approximately 100 days.

Type 2 Diabetes Mellitus

Eli Lilly and Company15 participantsStarted Oct 2024

Los Angeles, California, United States • Atlanta, Georgia, United States • Columbus, Georgia, United States +7 more locations

RECRUITINGPhase 3< 1 mile

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

NCT04786262

This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia.

Diabetes Mellitus, Type 1Impaired Hypoglycemic AwarenessSevere Hypoglycemia

Vertex Pharmaceuticals Incorporated52 participantsStarted Mar 2021

Duarte, California, United States • San Francisco, California, United States • Miami, Florida, United States +26 more locations

A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

Diabetes Trials in Other Cities

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

Closed Loop and Education for Hypoglycemia Awareness Restoration

A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

Teplizumab in Pediatric Stage 2 Type 1 Diabetes

Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)

A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes

The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.

Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes

Siplizumab in T1DM

A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Type 1 Diabetes Extension Study

Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs

Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Healthy And Positive Pathways for Young People With Type 1 Diabetes (HAPPY T1D)

Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment

Other Conditions in Philadelphia